DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Author: Susan Kellner

February 22, 2023
Advances in Precision Medicine NGS Testing, and Breaking the Barriers with Clinical Trials

As researchers learn more about the DNA changes and proteins that drive cancer, they are better able to design treatments that target these proteins. May 12, 2023

Read More
February 10, 2023
New Device Detects Brain Tumors Early, From Urine

Membrane proteins in urine can indicate a brain tumor early, according to researchers at Nagoya University in Japan. The could avoid the need for invasive tests and increase the likelihood of tumors being detected early enough for surgery.

Read More

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram